Zobrazeno 1 - 10
of 67
pro vyhledávání: '"John S. Bevan"'
Publikováno v:
Endocrine Connections, Vol 6, Iss 8, Pp 580-588 (2007)
Purpose: High serum prolactin concentrations have been associated with adverse health outcomes in some but not all studies. This study aimed to examine the morbidity and all-cause mortality associated with hyperprolactinaemia. Methods: A population-
Externí odkaz:
https://doaj.org/article/becb78689a7b450091dda29a9863f587
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 6, Iss 8, Pp 580-588 (2007)
Endocrine Connections, Vol 6, Iss 8, Pp 580-588 (2007)
Purpose High serum prolactin concentrations have been associated with adverse health outcomes in some but not all studies. This study aimed to examine the morbidity and all-cause mortality associated with hyperprolactinaemia. Methods A population-bas
Publikováno v:
Clinical Endocrinology. 86:60-67
Objective To estimate the prevalence and incidence of hyperprolactinaemia. Hyperprolactinaemia is a common problem in endocrine practice, but its epidemiology has not been accurately established. Study design A population-based retrospective follow u
Autor:
Fabrice Bonneville, Louis-David Rivière, Stephan Petersenn, John S Bevan, Aude Houchard, Caroline Sert, Philippe J Caron, Gaal L Van, J Marek, P Nuutila, M Välimäki, C Ajzenberg, F Borson-Chazot, T Brue, P Caron, O Chabre, P Chanson, C Cortet Rudelli, B Delemer, J-M Kuhn, A Tabarin, K Badenhoop, C Berg, S Petersenn, C Schöfl, J Schopohl, S Cannavò, A Colao, L De Marinis, A Stades, A J van der Lely, P Kadıoğlu, J S Bevan, D Flanagan, P Trainer
Publikováno v:
European journal of endocrinology.
Objective Pituitary adenoma MRI T2 signal intensity associates with tumor characteristics including responsiveness to somatostatin analogs (SSAs). These analyses determined whether baseline T2 signal intensity predicts response to primary medical tre
Autor:
Isabelle Guillemin, Andrea Giustina, John S. Bevan, Xuan-Mai Truong Thanh, Stephan Petersenn, Felipe F. Casanueva, Marcello D. Bronstein, Philippe Chanson, Shlomo Melmed, Caroline Sert, Aude Houchard
Publikováno v:
Pituitary
Purpose The SAGIT instrument is a comprehensive clinician-reported outcome instrument assessing key features of acromegaly: signs and symptoms, associated comorbidities; growth hormone levels; insulin-like growth factor-1 levels; and tumor profile. T
Publikováno v:
Endocrine Abstracts.
Autor:
Lynne Millar-Jones, Louise Izatt, Sarah A. Howles, M. Andrew Nesbit, Lisa Robertson, Peter Selby, Caroline M Gorvin, John S. Bevan, Angela Rogers, Shirley Hodgson, Treena Cranston, Simon H. S. Pearce, Caroline Brain, Gul Bano, Jeremy Allgrove, Brian Shine, Fadil M. Hannan, Katie Snape, Ashley B. Grossman, Vipan Datta, Rajesh V. Thakker, Justin T. Warner
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:E1300-E1305
CONTEXT: Autosomal dominant hypocalcemia (ADH) types 1 and 2 are due to calcium-sensing receptor (CASR) and G-protein subunit-α11 (GNA11) gain-of-function mutations, respectively, whereas CASR and GNA11 loss-of-function mutations result in familial
Autor:
Dr Kevin Shotliffe, Dr Annabel Fountain, Dr Mike Jones, Dr Jennifer Gray, Dr Richard Leach, Mr Neil Morton, Dr Anthony Toft, Professor John S Bevan, Dr Louella Vaughan
Chapter 10 covers endocrinology and metabolic disorders, including diabetes and diabetic coma, abnormalities of sodium and potassium, calcium, magnesium, and phosphate, metabolism, acid-base balance, thyroid emergencies, pituitary emergencies, adrena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39217f6ac7c5001545c136169098a6db
https://doi.org/10.1093/med/9780199565979.003.00010
https://doi.org/10.1093/med/9780199565979.003.00010
Autor:
S. McGeoch, John S. Bevan, N. N. Zammitt, Malcolm Donaldson, Syed Faisal Ahmed, M Ahmid, V. Fisher, Alex Graveling, Edward McNeil, Graham P. Leese, Colin Perry, Avril Mason, Louise Bath, M G Shaikh, J. Roach
Publikováno v:
International Journal of Pediatric Endocrinology
Background Adolescents with childhood onset growth hormone deficiency (CO-GHD) require re-evaluation of their growth hormone (GH) axis on attainment of final height to determine eligibility for adult GH therapy (rhGH). Aim Retrospective multicentre r
Publikováno v:
Clinical endocrinology. 86(4)
Objective Impaired glycaemic control, characteristic of acromegaly, can be exacerbated by treatment with somatostatin analogues (SSAs), particularly those with multireceptor activity. We present data from the PRIMARYS study on the impact of the SSA l